135 related articles for article (PubMed ID: 10628552)
1. [11C]-methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl)-methyl]-1- piperazinecarboxylate ([11C]GR89696): synthesis and in vivo binding to kappa opiate receptors.
Ravert HT; Mathews WB; Musachio JL; Scheffel U; Finley P; Dannals RF
Nucl Med Biol; 1999 Oct; 26(7):737-41. PubMed ID: 10628552
[TBL] [Abstract][Full Text] [Related]
2. [(11)C]-GR89696, a potent kappa opiate receptor radioligand; in vivo binding of the R and S enantiomers.
Ravert HT; Scheffel U; Mathews WB; Musachio JL; Dannals RF
Nucl Med Biol; 2002 Jan; 29(1):47-53. PubMed ID: 11786275
[TBL] [Abstract][Full Text] [Related]
3. 11C-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: synthesis and evaluation in baboons.
Talbot PS; Narendran R; Butelman ER; Huang Y; Ngo K; Slifstein M; Martinez D; Laruelle M; Hwang DR
J Nucl Med; 2005 Mar; 46(3):484-94. PubMed ID: 15750163
[TBL] [Abstract][Full Text] [Related]
4. Methylated analogues of methyl (R)-4-(3,4-dichlorophenylacetyl)- 3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate (GR-89,696) as highly potent kappa-receptor agonists: stereoselective synthesis, opioid-receptor affinity, receptor selectivity, and functional studies.
Soukara S; Maier CA; Predoiu U; Ehret A; Jackisch R; Wünsch B
J Med Chem; 2001 Aug; 44(17):2814-26. PubMed ID: 11495592
[TBL] [Abstract][Full Text] [Related]
5. Radiosynthesis and ex vivo evaluation of [11C]-SIB-1553A as a PET radiotracer for beta4 selective subtype nicotinic acetylcholine receptor.
Sobrio F; Quentin T; Dhilly M; Bourdier T; Tymciu S; Debruyne D; Barré L
Nucl Med Biol; 2008 Apr; 35(3):377-85. PubMed ID: 18355694
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vivo evaluation of [11C]SA6298 as a PET sigma1 receptor ligand.
Kawamura K; Ishiwata K; Tajima H; Ishii S; Shimada Y; Matsuno K; Homma Y; Senda M
Nucl Med Biol; 1999 Nov; 26(8):915-22. PubMed ID: 10708305
[TBL] [Abstract][Full Text] [Related]
7. Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation.
Li S; Zheng MQ; Naganawa M; Gao H; Pracitto R; Shirali A; Lin SF; Teng JK; Ropchan J; Huang Y
Mol Pharm; 2019 Apr; 16(4):1523-1531. PubMed ID: 30726092
[TBL] [Abstract][Full Text] [Related]
8. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
9. Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors.
Langer O; Halldin C; Dollé F; Swahn CG; Olsson H; Karlsson P; Hall H; Sandell J; Lundkvist C; Vaufrey F; Loc'h C; Crouzel C; Mazière B; Farde L
Nucl Med Biol; 1999 Jul; 26(5):509-18. PubMed ID: 10473189
[TBL] [Abstract][Full Text] [Related]
10. [11C]-MeJDTic: a novel radioligand for kappa-opioid receptor positron emission tomography imaging.
Poisnel G; Oueslati F; Dhilly M; Delamare J; Perrio C; Debruyne D; Barré L
Nucl Med Biol; 2008 Jul; 35(5):561-9. PubMed ID: 18589300
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probes.
de Costa BR; Rice KC; Bowen WD; Thurkauf A; Rothman RB; Band L; Jacobson AE; Radesca L; Contreras PC; Gray NM
J Med Chem; 1990 Nov; 33(11):3100-10. PubMed ID: 2172538
[TBL] [Abstract][Full Text] [Related]
13. 11C-labeling of n-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors.
Turolla EA; Matarrese M; Belloli S; Moresco RM; Simonelli P; Todde S; Fazio F; Magni F; Kienle MG; Leopoldo M; Berardi F; Colabufo NA; Lacivita E; Perrone R
J Med Chem; 2005 Nov; 48(22):7018-23. PubMed ID: 16250661
[TBL] [Abstract][Full Text] [Related]
14. 6-Chloro-3-(((1-[11C]methyl)-2-(S)-pyrrolidinyl)methoxy)-5-(2-fluoropyridin-4-yl)pyridine ([11C]JHU85270), a potent ligand for nicotinic acetylcholine receptor imaging by positron emission tomography.
Gao Y; Ravert HT; Holt D; Dannals RF; Horti AG
Appl Radiat Isot; 2007 Aug; 65(8):947-51. PubMed ID: 17566748
[TBL] [Abstract][Full Text] [Related]
15. Carbon-11 pb-12: an attempt to visualize the dopamine d(4) receptor in the primate brain with positron emission tomography.
Langer O; Halldin C; Chou Y; Sandell J; Swahn C; Någren K; Perrone R; Berardi F; Leopoldo M; Farde L
Nucl Med Biol; 2000 Nov; 27(8):707-14. PubMed ID: 11150701
[TBL] [Abstract][Full Text] [Related]
16. A potent new class of kappa-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines.
Naylor A; Judd DB; Lloyd JE; Scopes DI; Hayes AG; Birch PJ
J Med Chem; 1993 Jul; 36(15):2075-83. PubMed ID: 8393489
[TBL] [Abstract][Full Text] [Related]
17. Radiosynthesis of [11C]BBAC and [11C]BBPC as potential PET tracers for orexin2 receptors.
Liu F; Majo VJ; Prabhakaran J; Castrillion J; Mann JJ; Martinez D; Kumar JS
Bioorg Med Chem Lett; 2012 Mar; 22(6):2172-4. PubMed ID: 22364813
[TBL] [Abstract][Full Text] [Related]
18. Characterization of kappa1-opioid receptor binding in human insular cortex.
Izenwasser S; Staley JK; Cohn S; Mash DC
Life Sci; 1999; 65(9):857-62. PubMed ID: 10465345
[TBL] [Abstract][Full Text] [Related]
19. Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging.
Placzek MS; Schroeder FA; Che T; Wey HY; Neelamegam R; Wang C; Roth BL; Hooker JM
ACS Chem Neurosci; 2019 Jan; 10(1):384-395. PubMed ID: 30212182
[TBL] [Abstract][Full Text] [Related]
20. 123I-MSP and F[11C]MSP: new selective 5-HT2A receptor radiopharmaceuticals for in vivo studies of neuronal 5-HT2 serotonin receptors. Synthesis, in vitro binding study with unlabelled analogues and preliminary in vivo evaluation in mice.
Samnick S; Remy N; Ametamey S; Bader JB; Brandau W; Kirsch CM
Life Sci; 1998; 63(22):2001-13. PubMed ID: 9839544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
